153 related articles for article (PubMed ID: 27697674)
21. Vitamin D is negatively associated with triglyceride in overweight/obese patients with type 2 diabetes.
Gong T; Di H; Han X; Hu X; Liu C; Chen G
Endocrine; 2022 May; 76(2):304-311. PubMed ID: 35247144
[TBL] [Abstract][Full Text] [Related]
22. High protein weight loss diets in obese subjects with type 2 diabetes mellitus.
Pedersen E; Jesudason DR; Clifton PM
Nutr Metab Cardiovasc Dis; 2014 May; 24(5):554-62. PubMed ID: 24374004
[TBL] [Abstract][Full Text] [Related]
23. Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias.
Sakai S; Nakaseko C; Takeuchi M; Ohwada C; Shimizu N; Tsukamoto S; Kawaguchi T; Jiang M; Sato Y; Ebinuma H; Yokote K; Iwama A; Fukamachi I; Schneider WJ; Saito Y; Bujo H
Clin Chim Acta; 2012 Oct; 413(19-20):1542-8. PubMed ID: 22750733
[TBL] [Abstract][Full Text] [Related]
24. Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage.
Vázquez LA; Rodríguez Á; Salvador J; Ascaso JF; Petto H; Reviriego J
BMC Cardiovasc Disord; 2014 Nov; 14():153. PubMed ID: 25361574
[TBL] [Abstract][Full Text] [Related]
25. Circulating soluble LR11, a novel marker of smooth muscle cell proliferation, is enhanced after coronary stenting in response to vascular injury.
Ogita M; Miyauchi K; Jiang M; Kasai T; Tsuboi S; Naito R; Konishi H; Dohi T; Yokoyama T; Okazaki S; Shimada K; Bujo H; Daida H
Atherosclerosis; 2014 Nov; 237(1):374-8. PubMed ID: 25443876
[TBL] [Abstract][Full Text] [Related]
26. Effects of nutrition therapy on HbA1c and cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes.
Mottalib A; Salsberg V; Mohd-Yusof BN; Mohamed W; Carolan P; Pober DM; Mitri J; Hamdy O
Nutr J; 2018 Apr; 17(1):42. PubMed ID: 29626933
[TBL] [Abstract][Full Text] [Related]
27. Increased circulating soluble LR11 in patients with acute coronary syndrome.
Ogita M; Miyauchi K; Dohi T; Tsuboi S; Miyazaki T; Yokoyama T; Yokoyama K; Shimada K; Kurata T; Jiang M; Bujo H; Daida H
Clin Chim Acta; 2013 Jan; 415():191-4. PubMed ID: 23127357
[TBL] [Abstract][Full Text] [Related]
28. Overweight and obese youth with type 1 or type 2 diabetes share similar elevation in triglycerides during middle and late adolescence.
Ashour D; AlSubaihin A; Lim YY; Legault L
Obes Res Clin Pract; 2022; 16(2):138-143. PubMed ID: 35430167
[TBL] [Abstract][Full Text] [Related]
29. G-CSF induces the release of the soluble form of LR11, a regulator of myeloid cell mobilization in bone marrow.
Shimizu N; Nakaseko C; Jiang M; Nishii K; Yokote K; Iseki T; Higashi M; Tamaru J; Schneider WJ; Bujo H
Ann Hematol; 2014 Jul; 93(7):1111-22. PubMed ID: 24577511
[TBL] [Abstract][Full Text] [Related]
30. Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals.
Ni Y; Zhao L; Yu H; Ma X; Bao Y; Rajani C; Loo LW; Shvetsov YB; Yu H; Chen T; Zhang Y; Wang C; Hu C; Su M; Xie G; Zhao A; Jia W; Jia W
EBioMedicine; 2015 Oct; 2(10):1513-22. PubMed ID: 26629547
[TBL] [Abstract][Full Text] [Related]
31. Circulating soluble LR11, a differentiation regulator for vascular cells, is increased during pregnancy and exaggerated in patients with pre-eclampsia.
Ishida H; Jiang M; Ebinuma H; Hiruta N; Schneider WJ; Kinoshita T; Bujo H
Clin Chim Acta; 2019 Oct; 497():172-177. PubMed ID: 31299181
[TBL] [Abstract][Full Text] [Related]
32. Soluble LR11 as a Novel Biomarker in Acute Kawasaki Disease.
Watanabe K; Suzuki H; Jiang M; Tsukano S; Kataoka S; Ito S; Sakai T; Hirokawa T; Haniu H; Numano F; Hoshina S; Hasegawa S; Matsunaga M; Chiba K; Saito N; Yoshida H; Takami S; Okubo S; Hirano H; Saitoh A; Bujo H
Circ J; 2022 May; 86(6):977-983. PubMed ID: 34526431
[TBL] [Abstract][Full Text] [Related]
33. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
Ybarra J; James RW; Makoundou V; Bioletto S; Golay A
Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380
[TBL] [Abstract][Full Text] [Related]
34. Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans.
Whittle AJ; Jiang M; Peirce V; Relat J; Virtue S; Ebinuma H; Fukamachi I; Yamaguchi T; Takahashi M; Murano T; Tatsuno I; Takeuchi M; Nakaseko C; Jin W; Jin Z; Campbell M; Schneider WJ; Vidal-Puig A; Bujo H
Nat Commun; 2015 Nov; 6():8951. PubMed ID: 26584636
[TBL] [Abstract][Full Text] [Related]
35. Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes.
Berk KA; Yahya R; Verhoeven AJM; Touw J; Leijten FP; van Rossum EF; Wester VL; Lips MA; Pijl H; Timman R; Erhart G; Kronenberg F; Roeters van Lennep JE; Sijbrands EJG; Mulder MT
Diabetologia; 2017 Jun; 60(6):989-997. PubMed ID: 28386638
[TBL] [Abstract][Full Text] [Related]
36. Changes of serum omentin-1 levels in normal subjects, type 2 diabetes and type 2 diabetes with overweight and obesity in Chinese adults.
Zhang Q; Zhu L; Zheng M; Fan C; Li Y; Zhang D; He Y; Yang H
Ann Endocrinol (Paris); 2014 Jul; 75(3):171-5. PubMed ID: 24997770
[TBL] [Abstract][Full Text] [Related]
37. Improvements in glucose metabolism and insulin sensitivity with a low-carbohydrate diet in obese patients with type 2 diabetes.
Krebs JD; Bell D; Hall R; Parry-Strong A; Docherty PD; Clarke K; Chase JG
J Am Coll Nutr; 2013; 32(1):11-7. PubMed ID: 24015695
[TBL] [Abstract][Full Text] [Related]
38. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.
; Wing RR
Arch Intern Med; 2010 Sep; 170(17):1566-75. PubMed ID: 20876408
[TBL] [Abstract][Full Text] [Related]
39. Sex differences in the effect of HbA1c-defined diabetes on a wide range of cardiovascular disease risk factors.
Du T; Yuan G; Zhou X; Sun X
Ann Med; 2016; 48(1-2):34-41. PubMed ID: 26758477
[TBL] [Abstract][Full Text] [Related]
40. Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial.
Li X; Cai X; Ma X; Jing L; Gu J; Bao L; Li J; Xu M; Zhang Z; Li Y
Nutrients; 2016 Sep; 8(9):. PubMed ID: 27618090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
